| 0069-0238 |
Ruxience |
rituximab-pvvr |
Pfizer Laboratories Div Pfizer Inc |
INJECTION, SOLUTION |
|
2020-01-23 |
| 0069-0249 |
Ruxience |
rituximab-pvvr |
Pfizer Laboratories Div Pfizer Inc |
INJECTION, SOLUTION |
|
2020-01-23 |
| 0078-0669 |
ARZERRA |
ofatumumab |
Novartis Pharmaceuticals Corporation |
INJECTION, SOLUTION |
|
2016-02-01 |
| 0078-0690 |
ARZERRA |
ofatumumab |
Novartis Pharmaceuticals Corporation |
INJECTION, SOLUTION |
|
2016-02-01 |
| 0078-1007 |
KESIMPTA |
ofatumumab |
Novartis Pharmaceuticals Corporation |
INJECTION, SOLUTION |
|
2009-10-26 |
| 50242-051 |
Rituxan |
rituximab |
Genentech, Inc. |
INJECTION, SOLUTION |
|
1997-11-26 |
| 50242-053 |
Rituxan |
rituximab |
Genentech, Inc. |
INJECTION, SOLUTION |
|
1997-11-26 |
| 50242-070 |
Gazyva |
obinutuzumab |
Genentech, Inc. |
INJECTION, SOLUTION, CONCENTRATE |
|
2013-11-01 |
| 50242-108 |
Rituxan Hycela |
rituximab and hyaluronidase |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2017-06-22 |
| 50242-109 |
Rituxan Hycela |
rituximab and hyaluronidase |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2017-06-22 |
| 50242-125 |
Columvi |
Glofitamab |
Genentech, Inc. |
SOLUTION, CONCENTRATE |
|
2023-06-15 |
| 50242-127 |
Columvi |
Glofitamab |
Genentech, Inc. |
CONCENTRATE |
|
2023-06-15 |
| 50242-150 |
OCREVUS |
ocrelizumab |
Genentech, Inc. |
INJECTION |
|
2017-03-28 |
| 50242-554 |
Ocrevus Zunovo |
ocrelizumab and hyaluronidase |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2024-09-13 |
| 55513-224 |
Riabni |
rituximab-arrx |
Amgen, Inc |
INJECTION, SOLUTION |
|
2021-01-06 |
| 55513-326 |
Riabni |
rituximab-arrx |
Amgen, Inc |
INJECTION, SOLUTION |
|
2021-01-06 |
| 63459-103 |
Truxima |
rituximab-abbs |
Cephalon, Inc. |
INJECTION, SOLUTION |
|
2020-05-04 |
| 63459-104 |
Truxima |
rituximab-abbs |
Cephalon, Inc. |
INJECTION, SOLUTION |
|
2020-05-04 |
| 73150-150 |
BRIUMVI |
ublituximab |
TG Therapeutics, Inc. |
INJECTION, SOLUTION, CONCENTRATE |
|
2022-12-28 |
| 82705-002 |
EPKINLY |
epcoritamab-bysp |
Genmab US, Inc. |
INJECTION, SOLUTION |
|
2023-05-19 |
| 82705-010 |
EPKINLY |
epcoritamab-bysp |
Genmab US, Inc. |
INJECTION, SOLUTION |
|
2023-05-19 |